---

---

---

•	Our Key Businesses Have Industry Leading Positions: Our key businesses and many of our products hold leading positions within the various industries they serve. We believe our scale and global reach in product development and marketing provide us with advantages over many of our smaller competitors.

•	Broad Diversified Business:

•

Geographic Diversity. Our worldwide manufacturing, sales and marketing network enables us to serve the needs of both local and global customers worldwide. As of December 31, 2015, we operated 20 manufacturing facilities in 11 countries. For the year ended December 31, 2015, 46% of our net sales were generated in the United States and Canada, 29% from Europe and Africa, 21% from Asia/Pacific and 4% from Latin America. We market and sell our products in approximately 90 countries, providing the opportunity to develop new markets for our products in higher-growth regions. We have built upon our historical strength in the United States and Europe to expand our business geographically, thereby diversifying our exposure to many different economies.

•	GEOGRAPHIC INFORMATION

•	Product and Industry Diversity. We are comprised of a number of distinct businesses based on different chemistries, each of which is subject to a set of varied industry trends. Additionally, the product lines of each of our businesses serve a variety of industries and applications, thereby providing us with further diversification.

•	Diversified Customer Base. We have a large and diverse global customer base in a broad array of industries and applications. No single customer comprises more than ten percent of our consolidated 2015 net sales.

•

Unique Industry Positions: We believe our businesses possess significant differentiation within their respective industry segments. Some of our businesses are vertically integrated into key feedstocks or have long lead time product registrations or technical and formulatory know-how. We believe these attributes are difficult to replicate and allow us to attract customers looking for consistent performance, reliability and cost-effective results, and are distinct competitive advantages. Examples include:

•	Our Industrial Performance Products segment participates in a production joint venture that produces cost competitive alkylated diphenylamine, a building block for our Naugalube® antioxidants used in lubricants, and develops urethane systems, the production of which is enhanced by our technical and formulatory know-how that permits us to engineer our products to meet specific customer needs.

---

•

Our Industrial Engineered Products segment has a strong diversified position in bromine with an extensive brine field operation in South Arkansas and long-term strategic sourcing agreements that provide access to Dead Sea and additional South Arkansas bromine. Bromine is used as a building block for products such as flame retardants used in automotive, electronics, building and construction, and brominated derivatives used in pharmaceutical, agriculture, and energy-based industry segments. Our high-purity organometallics products are based on more than 50 years of innovation and safe handling and provide state of the art solutions to rapidly developing new applications such as the chemical vapor deposition of metal oxide layers in electronics and photovoltaics, pharmaceutical synthesis reagents and next generation polymerization catalysts.

•

Well Positioned to Expand in the Faster Growing Regions: Our businesses’ product portfolios have positioned us to benefit from high-growth regions in the future. We derived 25% of our revenues during 2015 from the faster growing regions of Asia/Pacific and Latin America. Despite current economic uncertainty in the faster growing regions, we will continue to build our presence in these regions as we believe that their polymer production will increase, their manufacturing of electronic products will expand and their automotive industries will build vehicles that have to meet emission standards such that they can be exported to western markets. There are a limited number of suppliers that can supply the products or provide the technical support that customers in these regions require, giving us the opportunity to capture this growth in demand for our products. We have completed the construction of a multi-purpose manufacturing plant in China which has commenced production of high-performance specialty greases and synthetic lubricants and is expected to commence production of high-performance urethane products in early 2016.

•

Technology-Driven Growth through Industry Focused Innovation. As an industrial specialty chemical developer and manufacturer, our competitive strength lies in continually developing and engineering new products and processes that meet our customers’ changing needs. We are investing in innovation to strengthen our new product pipelines and to reduce the cost of our products and will license or acquire technologies to supplement these initiatives. We focus on the development of products that are sustainable, meet ecological concerns and capitalize on growth trends in the industries we serve.

•

Growth Expansion in Faster-Growing Regions through Building Global Scale. We are building our local presence in the faster-growing regions through sales representation, technical development centers, joint ventures and local manufacturing. We empower our regional teams to serve their growing customer base and will supplement these efforts through bolt-on acquisitions that fulfill our goals for our portfolio. We leverage our global scale by sharing service functions and technologies that no one region or business could replicate on its own while utilizing our regional presence to lower raw material costs.

•

Performance-Driven Culture. We believe we have outstanding people who can deliver superior performance under strong, experienced leaders who instill a culture of accountability. We expect accountability on safety, environmental stewardship, compliance with laws, customer commitments and performance. We are focused on understanding the needs of our customers and meeting such needs by efficiently executing their orders and delivering technology-based solutions that meet their requirements to earn the position as their preferred supplier. We measure our performance against benchmarks and metrics using statistical analysis and drive operational excellence through continuous improvement.

•

Portfolio and Cost Management. We will continue to build upon our strengths as an industrial specialty chemical company through organic growth complemented by acquisition or merger to expand our global industrial specialty chemical portfolio to maximize their value. As we grow, we may conclude to divest portfolio businesses too. We are intent that any Chemtura portfolio business must have sustainable competitive advantages in the industries and applications it serves and can leverage its technology, scale and customer intimacy required to drive profitable growth at returns in excess of its cost of capital. The ability to leverage global demographic and technology trends combined with our in-depth knowledge and expertise will provide our portfolio businesses with the “right to play” in their chosen applications. We will continue to drive value-accreting growth fueled by our focus on innovation and the faster-growing

---

•	synthetic base-stocks and petroleum additives that enable engine and machine protection through friction reduction, thermal and oxidative stabilization, detergency, corrosion inhibition, and wear protection in transportation and industrial lubricating fluids and greases;

•	specialty synthetic finished lubricants and greases for aviation, marine, refrigeration, power generation and general industrial applications;

•	thermoset and thermoplastic urethane polymers engineered to provide superior performance properties in a broad range of industrial and recreational applications; and

•	polyester polyols for cast polyurethane pre-polymers, flexible polyurethane foams and water-based polyurethane dispersions used in various types of coatings such as wood floor finishes, glass fiber coatings and textile treatments.

---

---

---

---

---

---

•	compliance with U.S. laws affecting operations outside of the United States, such as Office of Foreign Assets Control trade sanction regulations and anti-boycott regulations;

•	compliance with anti-corruption laws, including Foreign Corrupt Practices Act and U.K. Bribery Act;

•	compliance with antitrust and competition laws, data privacy laws, and a variety of other local, national and multi-national regulations and laws in multiple regimes;

•	changes in tax laws, interpretation of tax laws and tax audit outcomes;

•	fluctuations or devaluations in currency values, especially in emerging markets;

•	changes in capital controls, including currency exchange controls, government currency policies or other limits on our ability to import raw materials or finished product or repatriate cash from outside the United States;

•	changes in local regulations and laws, the uncertainty of enforcement of remedies in foreign jurisdictions, and foreign ownership restrictions and the potential for nationalization or expropriation of property or other resources;

•	discriminatory or conflicting fiscal policies;

•	increased sovereign risk, such as default by or deterioration in the economies and credit worthiness of local governments;

•	varying abilities to enforce intellectual property and contractual rights;

•	greater risk of uncollectible accounts and longer collection cycles;

•	design and implementation of effective control environment processes across our diverse operations and employee base; and

•	imposition of more or new tariffs, quotas, trade barriers, and similar restrictions on our sales or regulations, taxes or policies that might negatively affect our sales.

---

---

---

---

---

---

•	cease selling products that contain asserted intellectual property;

•	pay substantial damages for past use of the asserted intellectual property;

•	obtain a license from the holder of the asserted intellectual property, which may not be available on reasonable terms; and

•	redesign or rename, in the case of trademark claims, our products to avoid infringing the rights of third parties.

---

---

---

---

---

---

1.	Facility leased by Anderol Italia S.r.l, of which we own 51% .

---

---

---

---

(a)	Net sales includes $38 million and $6 million in 2015 and 2014, respectively, related to the non-cash portion of the recognition of our fulfillment, net of accretion, of our below-market contract obligations associated with the sale of our Chemtura AgroSolutions business in 2014.

(b)	Gain on sale of business primarily included a $529 million gain on the sale of our Chemtura AgroSolutions business in 2014 and $27 million gain on the sale of our 50% interest in Tetrabrom Technologies Ltd. in 2011.

(c)	The 2011 charge primarily included the impairment of intangible assets of $3 million within the Agrochemical Manufacturing segment.

(d)

In March 2009, Chemtura and 26 of our affiliates filed for relief under Chapter 11 of Title 11 of the United States Code ("Chapter 11") the United States Bankruptcy Court for the Southern District of New York (the "Bankruptcy Court"). In November 2010, the Bankruptcy Court entered an order confirming our plan of reorganization (the "Plan"). Changes in estimates related to expected allowable claims relate to adjustments to liabilities subject to compromise (primarily legal and environmental reserves) as a result of our Chapter 11 proof of claims evaluation process.

(e)	Reorganization items, net, represents professional fees, impacts from the settlement of claims and charges for reorganization initiatives.

(f)

In the fourth quarter of 2015, we elected to early adopt on a prospective basis the provisions of Accounting Standards Update No. 2015-17 Balance Sheet Classification of Deferred Taxes ("ASU 2015-17"), which requires that deferred tax liabilities and assets and related valuation allowances be classified as non-current on the balance sheet. Previous to this adoption deferred tax assets or liabilities and related valuation allowances could be classified as either current or non-current depending on the nature of the assets or liability that gave rise to the deferred tax position. Given that we elected prospective adoption, we did not reclassify prior year information to conform with ASU 2015-17.

---

•	Risks associated with significant international operations and interests;

•	Increases in the price of raw materials or energy and our ability to recover cost increases through increased sales prices for our products;

•	Disruptions in the availability of raw materials or energy;

•	Operating risks at our production facilities;

•	Risks associated with maintenance of existing facilities and construction of new facilities;

•	Failure to develop new products and our ability to remain technologically innovative and offer improved products in a cost-effective manner;

•	The cyclical nature of the global chemicals industry;

•	Failure to accurately forecast market and customer trends for our products;

•	Declines in general economic conditions;

•	Significant competition in many of the markets in which we operate;

•	Loss of or significant reduction in purchases by our largest customers;

•	Our products are subject to extensive government scrutiny and regulation;

•	Environmental, health and safety regulations;

•	Current and future litigation, governmental investigations, prosecutions and administrative proceedings;

•	Military conflicts and terrorism;

•	Federal regulations aimed at increasing security at certain chemical production plants;

•	Our ability to protect our patents or other intellectual property rights;

•	Our ability to reduce the risks of cyber incidents and protect our information technology;

•	Risks associated with possible climate change legislation, regulation and international accords;

•	Risks associated with strategic acquisitions, partnerships and other strategic opportunities;

•	Our dependence upon a trained, dedicated sales force;

•	Exchange rate and other currency risks;

•	Our unfunded and underfunded defined benefit pension plans and post-retirement welfare benefit plans;

•	Risks associated with Joint Ventures;

•	Restrictive covenants in our credit facilities;

•	Deferred tax assets and utilization of our net operating losses;

•	The ability to support the carrying value of the goodwill and long-lived assets related to our businesses;

•	Estimates and judgments relating to our accounting policies;

•	Our ability to maintain adequate internal controls over financial reporting;

•	Actions of activist shareholders;

•	Issuance of additional shares of stock and resulting dilution; and

•	Other risks and uncertainties detailed in Item 1A - Risk Factors in our filings with the Securities and Exchange Commission.

---

---

•	We announced in late 2014 a cost reduction program to deliver $62 million annualized incurred cost savings indicating we would realize $50 million of savings in 2015. We delivered on that commitment and achieved our "run-rate" savings in incurred costs in the third quarter of 2015 although part of the benefit was offset by the absorption effect of lower sales volume.

•	We promptly eliminated the stranded costs associated with our former Chemtura AgroSolutions business. We also completed the closure of our West Lafayette, Indiana and Adrian, Michigan facilities. These actions together with the manufacturing and SG&A cost reduction program substantially completed the 2014 Restructuring Plan.

•

We increased the percentage of operating income to net sales in our Industrial Performance and Industrial Engineered segments by 520 basis points and 600 basis points, respectively, for the year ended December 31, 2015 as compared with prior year end despite a reduction in net sales for the same periods. The improvement came from the benefits of our cost reduction actions and from "price-over-raw material costs", among other factors.

•	We demonstrated substantial improvements in cash flow. Net cash flow provided by operating activities was $159 million, an improvement of $237 million from 2014 when we used cash. Capital expenditures declined as planned from $113 million in 2014 to $80 million in 2015.

•	We continued to drive our commercial and operational excellence initiatives, improving our customers' experience and our operating effectiveness.

•	We continued to reduce the number of our legal entities, primarily through liquidation, eliminating the costs of regulatory and other compliance. As a result, in the fourth quarter of 2015, we recorded an $8 million gain due to the release of accumulated foreign currency translation adjustments on these liquidations.

•	During 2015, we repurchased 6.2 million shares of our common stock under our share repurchase program at a cost of $150 million. As of December 31, 2015, $171 million remained outstanding under our Board authorized share repurchase program to fund further repurchases in 2016.

•	During 2015, we reduced our outstanding debt by $57 million primarily the result of payments made with proceeds from the sale of our Chemtura AgroSolutions business and cash on hand, lowering our total debt to $517 million as of December 31, 2015.

•	We reduced interest expense by $15 million for the year ended December 31, 2015 as compared with the prior year end due to debt repayments made in 2015 and late 2014.

•	With the combination of improved operating profitability and cash flows and the reductions in debt outstanding, we ended 2015 with our total debt close to our long term financial goal of 2 times Adjusted EBITDA (Adjusted EBITDA is defined in this section under the heading ADJUSTED EBITDA).

•

During the second quarter of 2015, we sold 2 million shares of Platform common stock that we had received as part of the purchase price consideration when we sold our Chemtura AgroSolutions business to Platform in 2014 for net cash proceeds of $54 million. As a result of holding the shares, which were accounted for as available for sale securities, we reported a net gain of $3 million in the second quarter of 2015.

---

---

---

(a)

Price over raw materials is the sum of the net changes in sales prices and the net changes in raw material costs between the two periods. As the reduction in the costs of certain raw materials result in certain circumstances in reductions in sales prices under certain contractual and negotiated agreements, the change in sales prices net of changes in raw material costs provides a better measure of the impact of sales price changes on our profitability (referred to as "price over raw materials").

---

---

---

---

(a)	Price over raw materials is the sum of the net changes in sales prices and the net changes in raw material costs between the two periods. As the reduction in the costs of certain raw materials result in certain circumstances in reductions in sales prices under certain contractual and negotiated agreements, the change in sales prices net of

---

---

---

---

---

---

---

---

*	Additional information is provided in various footnotes (including Debt, Leases, Legal Proceedings and Contingencies, Pension and Other Post-Retirement Plans, Income Taxes, and Divestitures) in our Notes to Consolidated Financial Statements.

(a)	Our debt agreements include various notes and bank loans for which payments will be payable through 2021. Obligations by period reflect stated contractual due dates. We are not required to make any cash payments under our capital lease obligations, therefore these amounts are excluded from the table above.

(b)	Represents operating lease obligations primarily related to buildings, land and equipment. Such obligations are net of future sublease income and will be expensed over the life of the applicable lease contracts. During 2015, we made payments of $16 million for operating leases.

(c)	Represents interest payments and fees related to our 2021 Senior Notes, Term Loan, ABL Facility and other debt obligations outstanding at December 31, 2015. Assumed interest rates are based upon rates in effect at December 31, 2015.

(d)	We have ongoing environmental liabilities for future remediation and operating and maintenance costs directly related to remediation. We estimate that the ongoing environmental liability could range up to $76 million. We have recorded a liability for ongoing environmental remediation of $63 million at December 31, 2015.

---

(e)	We have post-retirement health care plans that provide health and life insurance benefits to certain retired and active employees and their beneficiaries. These plans are generally not pre-funded and expenses are paid by us as incurred, with the exception of certain inactive government related plans that are paid from plan assets.

(a)	Represents minimum amounts required by law or contractual obligations. We may elect to make additional discretionary contributions as deemed appropriate consistent with our past practice.

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

---

(1)	The net assets sold primarily included accounts receivable; inventories; property, plant and equipment; and intangible assets offset by transferred pension and post-retirement health care liabilities; and other miscellaneous liabilities.

(2)	Transaction costs include legal fees and other direct costs incurred to sell the business.

(a)

Income tax expense on the sale of our Consumer Products business is primarily a cash tax charge for estimated U.S. Federal alternative minimum tax and state taxes. Deferred taxes in our non-U.S. entities are included in the calculation of the pre-tax loss on sale. However, the reversal of deferred tax assets and liabilities of our U.S. entities are included in tax expense, reflecting the election made to treat the sale of stock of the U.S. legal entities in the

---

---

---

---

---

---

---

---

---

•	At December 31, 2014, our U.S. operations had a 3 year cumulative pretax income of $258 million (including discontinued operations).

•

At December 31, 2014, our U.S. operations had a three year cumulative income of $38 million after excluding the contribution of the three businesses we divested in the period 2013-2014, the expense incurred to divest those businesses and of the gain/loss on those divestitures as well as including the benefit of lower interest expense arising from the pay down of debt with a portion of the proceeds from the divestitures.

•	The pay down of both third party and intercompany debt during 2013 and 2014 has reduced the interest expense (both third party and interest paid on loans from our foreign subsidiaries) of our U.S. operations by $18 million compared to what was incurred in 2013 and $36 million compared to what was incurred in 2012.

•

Our U.S. operations benefit from significant foreign source income from their international operations. A review of historic receipts of foreign source income, adjusted to exclude income from the divested businesses, or that arose from intercompany lending that has now been repaid, indicates that the U.S. operations can reasonably expect $15-20 million of recurring foreign source income annually. The benefit of the foreign source income reduces the value of U.S. pretax income that is required to fully utilize the U.S. federal NOL released each year by an equal amount.

•	Our U.S. Federal NOLs have a 20 year carryforward period and will expire in 2029 and 2030.

•

The U.S. federal NOL utilization is based on U.S. federal taxable income, which is comprised of pretax income, permanent items and reversals of temporary differences. As of December 31, 2014, we will need to generate approximately $725 million of pretax income over the next 16 years to realize all of our federal NOLs and absorb reversing temporary differences. The amount of pretax income needed to utilize the federal NOL is significantly less than our projected U.S. pretax income for the same time period. We believe our U.S. deferred tax liabilities will reverse in the same time period as our U.S. deferred tax assets.

•

The profitability of our U.S. operations are driven by the performance of our Great Lakes Solutions products manufactured in the U.S. Performance is expected to progressively improve in 2015 and in subsequent years initially led by our manufacturing and SG&A cost reduction programs. A significant portion of the actions to reduce manufacturing and SG&A costs (primarily reductions in headcount) have already been taken and in conjunction with improvement in manufacturing efficiencies and yields, will yield cost reductions of $26 million annually in the U.S..

---

•	We are not relying on any tax planning strategies as a source of U.S. income necessary to utilize our U.S. federal NOLs.

•

We disposed of two profitable businesses in 2013 (Consumer Products) and 2014 (Chemtura AgroSolutions). However, we have already eliminated the stranded costs associated with the Consumer Products business and we anticipate that we will eliminate the stranded cost associated with the Chemtura AgroSolutions business by the end of the first quarter of 2015. We have used a portion of the net after-tax sale proceeds to repay debt, reducing U.S. interest expense. We have also transferred pension liabilities to the buyers of the Antioxidants and Consumer Products business. We also refinanced a significant portion of our debt in 2013, further reducing interest expense from that in 2012 and prior years.

•

If we exclude the profit contribution of the Antioxidants, Consumer Products and Chemtura AgroSolutions businesses, U.S. operations incurred a loss in both 2013 and 2014. However, as indicated in positive evidence, these results adjusted for lower third party and intercompany interest expense in the U.S., eliminated costs incurred by the U.S. in support of the international operations of these businesses and the release of the obligations and the accretion related to the below market nature of the Supply Agreements, U.S. operations would have been profitable in these periods and was profitable in 2012.

•	In 2012 and 2013, our forecast of pretax income of our U.S. operations was not fully achieved. However, the achievement of U.S. pretax income forecasts in full is not required to fully utilize the Company’s U.S. deferred tax assets as they become available to offset U.S. taxable income.

•	At September 30, 2014 and December 31, 2013, our U.S. operations had a three-year cumulative loss of $105 million and $89 million, respectively, (including discontinued operations). The cumulative loss was eliminated by the gain on the sale of our Chemtura AgroSolutions business in the quarter ended December 31, 2014.

•	As a result of our emergence from Chapter 11 Bankruptcy in 2010, we will be subject to annual U.S. federal NOL limitations under Internal Revenue Code (“IRC”) Section 382 in the future. Our federal NOL annual limitation will be $72 million in 2015 and $59 million annually in the period 2016-2024 and $8 million in 2025.

•

At December 31, 2014, Chemtura had a deferred tax asset related to Low Income Housing credits (“LIH”) in the amount of $23 million; post 1998 LIH credits have a 20 year carry forward (the oldest is pre-2003 in the amount of $10 million). LIH credits are not available for use until all pre-Chapter 11 federal NOLs are utilized. Therefore, we do not believe it is more likely than not that we will utilize pre-Chapter 11 LIH credits before they expire.

---

---

---

---

---

---

---

---

(a)	The gains for 2015 primarily related to an update to the revised mortality tables for the U.S. pension plans, and increases in discount rates. The losses for 2014 primarily related to the utilization of the recently revised mortality tables for the U.S. pension plans and certain international plans, and decreases in discount rates.

(b)	The significant foreign currency decrease in 2015 and 2014 is due to decreases in Euro and British Pound exchange rates from December 2014 to December 2015 and from December 2013 to December 2014, respectively.

(a)	The significant foreign currency decrease in 2015 and 2014 is due to decreases in Euro and British Pound exchange rates from December 2014 to December 2015 and from December 2013 to December 2014, respectively.

---

(a)

Pooled equity funds include mutual and collective funds that invest primarily in marketable equity securities of various sized companies in a diverse set of industries in various regions of the world. Shares of publicly traded mutual funds are valued at the closing price reported on the U.S. and international exchanges where the underlying securities are actively traded. Units of collective funds are valued at the per unit value determined by the fund manager, which is based on market price of the underlying securities.

(b)	U.S. and international government bonds include U.S. treasury, municipal and agency obligations and international government debt. Such instruments are valued at quoted market prices for those instruments or on institutional bid valuations.

(c)	Pooled fixed income funds are fixed income funds that invest primarily in corporate and government bonds. Publicly traded funds are valued at the closing price in active markets and observable data, whereas collective funds are valued by broker or dealer quotations, which are based on the market price of the underlying securities.

(d)	Alternative collective funds include funds that invest mainly in asset backed securities, real estate funds, hedge funds and other alternative investments.  The underlying funds are valued based on the net asset values of the investments as determined by the respective individual fund administrators on a

---

(e)	Other instruments include primarily annuities and real estate funds instruments for which there are significant unobservable inputs and therefore have been classified as level 3.

---

(a)	The expected employer contributions reflect the minimum required by law or contractual obligation, including benefits paid directly by employer. We may elect to make additional discretionary contributions as deemed appropriate consistent with past practice.

(b)	The expected benefit payments are based on the same assumptions used to measure our benefit obligation at the end of the year and include benefits attributable to estimated future employee service.

---

(a)	The net periodic benefit cost for the year ended December 31, 2013 includes pension expense related to the earnings (loss) from discontinued operations of $1 million.

(b)

The settlement loss recognized in 2014 of $21 million relates to the lump sum payout made to certain participants in our U.S. qualified pension plan (included in SG&A). The settlement loss recognized in 2013 includes a loss of $40 million related to the divestiture of our Antioxidants business in April 2013 (included in loss on sale of discontinued operations), partly offset by a $2 million gain related to the divestiture of our Consumer Products business (included in loss on sale of discontinued operations) and a $6 million gain related to an adjustment for a legacy pension plan ($2 million included in SG&A and $4 million in loss from discontinued operations).

---

•	Level 1 – Quoted prices in active markets for identical assets and liabilities.

•	Level 2 – Quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active or other inputs that are observable or can be corroborated by observable market date.

•	Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets and liabilities.

---

---

---

---

---

---

---

---

---

---

---

---

---

---

(a)	Net sales included $9 million, $10 million, $10 million and $9 million in the first, second, third and fourth quarters of 2015, respectively, related to the non-cash portion of the amortization, net of accretion, of the below-market contract obligation associated with the sale of our Chemtura AgroSolutions business in 2014.

(b)	Net sales included $6 million in the fourth quarter of 2014 related to the non-cash portion of the amortization, net of accretion, of the below-market contract obligation associated with the sale of our Chemtura AgroSolutions business in 2014.

(c)	The earnings from continuing operations for the fourth quarter of 2014 included a pre-tax gain on the sale of the Chemtura AgroSolutions business of $529 million and pre-tax charges for facility closures, severance and related costs of $19 million and loss on early extinguishment of debt of $7 million.

(d)	The sum of the earnings (loss) per common share for the four quarters may not equal the total earnings (loss) per common share for the full year due to quarterly changes in the average number of shares outstanding.

---

---

---

---

---

1.	Financial statements and Report of Independent Registered Public Accounting Firm, as required by Item 8 of this form.

(i)	Consolidated Statements of Operations for the years ended December 31, 2015, 2014, and 2013;

(ii)	Consolidated Statements of Comprehensive Income for the years ended December 31, 2015, 2014, and 2013;

(iii)	Consolidated Balance Sheets as of December 31, 2015 and 2014;

(iv)	Consolidated Statements of Cash Flows for the years ended December 31, 2015, 2014, and 2013;

(v)	Consolidated Statements of Stockholders' Equity for the years ended December 31, 2015, 2014, and 2013;

(vi)	Notes to Consolidated Financial Statements; and

(vii)	Report of Independent Registered Public Accounting Firm.

2.	The following exhibits are either filed herewith or incorporated herein by reference to the respective reports and registration statements identified in the parenthetical clause following the description of the exhibit:

---

---

---